Amarex logo

Female scientist viewing autoradiogram dna in laboratory 1148109609

Market Approvals

Amarex has helped obtain the following market approvals:

  • 2020, 510(k) approval, 1copy™ COVID-19 qPCR Multi Kit, infectious disease
  • 2020, De Novo approval, EndeavorRx™, ADHD
  • 2019, De Novo approval, weight management aid, gastroenterology
  • 2019, 510(k) approval, Vstrip® H. pylori Antigen Rapid Test, infectious disease diagnostic
  • 2018, NDA approval, DIACOMIT®, anticonvulsant
  • 2017, 510(k) approval, gastroenterology/urology
  • 2016, PMA approval, dermal regeneration matrix, wound healing device
  • 2015, 510(k) approval, BondEase® Topical Skin Adhesive, wound healing device
  • 2010/2015, PMA approval, INSTI® HIV-1/HIV-2 Antibody Test Kit, diagnostic
  • 2013, NDA approval, Brisdelle™, vasomotor symptoms
  • 2013, NDA approval, pediatric inflammatory disease
  • 2012, NDA approval, Pexeva®, depression and anxiety
  • 2012, NDA approval, pain management
  • 2012, PMA approval, therascreen KRAS RGQ PCR Kit, oncology diagnostic
  • 2011, PMA approval, Solesta®, gastroenterology
  • 2009, NDA approval, QuitPak®, addiction
  • 2008, NDA approval, Amoxicillin PULSYS, infectious disease
  • 2008, NDA approval, Xenazine®, central nervous system
  • 2002, NDA approval, Abilify MyCite®, schizophrenia
  • 2001, NDA approval, Adderall XR®, ADHD
  • 2001, PMA approval, OrCel®, wound healing device
  • 2001, PMA approval, remnant-like particles-cholesterol (RLP-C) assay, diagnostic
  • 1999, NDA approval, Pletal®, cardiovascular
  • 1998, NDA approval, RAXAR™, infectious disease
  • Elderly male patient talking with female doctor 1212821220

    Therapeutic Areas

    We have more than two decades of experience successfully performing clinical trials in all major therapeutic areas.

Contact Us

Send us a message to talk to one of our experts.